| Anaemia | Blood and lymphatic system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0013 affected298 at risk
- EG0023 affected303 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Angina unstable | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0003 affected300 at risk
- EG0014 affected298 at risk
- EG0023 affected303 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Atrioventricular block first degree | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Bradycardia | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0013 affected298 at risk
- EG0020 affected303 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0013 affected298 at risk
- EG0026 affected303 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0004 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Palpitations | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Tachycardia | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Diverticular hernia | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Enterocolitis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Flatulence | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Gastric volvulus | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Gastroduodenitis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Oesophagitis ulcerative | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Rectal ulcer | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Chest pain | General disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Death | General disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| General physical health deterioration | General disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Impaired healing | General disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Abdominal sepsis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Bronchitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0013 affected298 at risk
- EG0020 affected303 at risk
|
| Campylobacter infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Cellulitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Cystitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Device related infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Diverticulitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Endocarditis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Infectious pleural effusion | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Influenza | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Perihepatic abscess | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Pneumonia | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0009 affected300 at risk
- EG00111 affected298 at risk
- EG0025 affected303 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Sepsis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0003 affected300 at risk
- EG0013 affected298 at risk
- EG0022 affected303 at risk
|
| Septic shock | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0013 affected298 at risk
- EG0021 affected303 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Accidental overdose | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Comminuted fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Dislocation of vertebra | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0005 affected300 at risk
- EG0012 affected298 at risk
- EG0024 affected303 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0014 affected298 at risk
- EG0020 affected303 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Forearm fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0003 affected300 at risk
- EG0013 affected298 at risk
- EG0023 affected303 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0022 affected303 at risk
|
| Internal injury | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Muscle rupture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Blood pressure increased | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Heart rate irregular | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Myocardial necrosis marker increased | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Prostatic specific antigen increased | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Troponin increased | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0012 affected298 at risk
- EG0022 affected303 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Iron deficiency | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0013 affected298 at risk
- EG0022 affected303 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Benign neoplasm of ureter | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Cholangiocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0013 affected298 at risk
- EG0021 affected303 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Malignant melanoma stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Malignant pleural effusion | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Myxofibrosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Neoplasm skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Neuroendocrine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Ovarian cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Plasma cell myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cerebral haematoma | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Cerebral microangiopathy | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0003 affected300 at risk
- EG0013 affected298 at risk
- EG0021 affected303 at risk
|
| Cervicogenic vertigo | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Dementia | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Dizziness | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Dural arteriovenous fistula | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Epilepsy | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Generalised tonic-clonic seizure | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Headache | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Presyncope | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Seizure | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Senile dementia | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0014 affected298 at risk
- EG0021 affected303 at risk
|
| Vertigo CNS origin | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0022 affected303 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Bladder cyst | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0013 affected298 at risk
- EG0020 affected303 at risk
|
| Oliguria | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Tubulointerstitial nephritis | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0013 affected298 at risk
- EG0020 affected303 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Bronchial hyperreactivity | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0013 affected298 at risk
- EG0025 affected303 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Epiglottic cyst | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Pneumothorax spontaneous | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Pulmonary air leakage | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cardiac pacemaker battery replacement | Surgical and medical procedures | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Blood pressure inadequately controlled | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Haematoma | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Hypertension | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Hypotension | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| May-Thurner syndrome | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Syncope | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0012 affected298 at risk
- EG0022 affected303 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Blindness transient | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0022 affected303 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Borderline glaucoma | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Choroidal neovascularisation | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Iritis | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0021 affected303 at risk
|
| Neovascular age-related macular degeneration | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0003 affected300 at risk
- EG0013 affected298 at risk
- EG0023 affected303 at risk
|
| Open angle glaucoma | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Retinal detachment | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0012 affected298 at risk
- EG0020 affected303 at risk
|
| Retinal neovascularisation | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Retinal tear | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Visual acuity reduced | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG00010 affected300 at risk
- EG00112 affected298 at risk
- EG0028 affected303 at risk
|
| Visual acuity reduced transiently | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Vitritis | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Conjunctivitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Endophthalmitis | Infections and infestations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0012 affected298 at risk
- EG0021 affected303 at risk
|
| Corneal abrasion | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Hyphaema | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Intraocular pressure increased | Investigations | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG00116 affected298 at risk
- EG00214 affected303 at risk
|
| Atrial septal defect | Congenital, familial and genetic disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Uterovaginal prolapse | Reproductive system and breast disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Dry age-related macular degeneration | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0002 affected300 at risk
- EG0010 affected298 at risk
- EG0022 affected303 at risk
|
| Cataract | Eye disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Gastrointestinal angiectasia | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Obstructive pancreatitis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Pyrexia | General disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Foreign body in eye | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Traumatic intracranial haemorrhage | Injury, poisoning and procedural complications | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Urethral cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0011 affected298 at risk
- EG0020 affected303 at risk
|
| Aphasia | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0000 affected300 at risk
- EG0010 affected298 at risk
- EG0021 affected303 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Embolic stroke | Nervous system disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA, version 20.1 | Systematic Assessment | | - EG0001 affected300 at risk
- EG0010 affected298 at risk
- EG0020 affected303 at risk
|